Guardant Health vs RadNet
GH and RDNT side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GH and RDNT compare
Guardant Health is the larger company, worth 3.4 times as much as RadNet ($20.8B against $6.1B).
Guardant Health grew revenue faster over the last twelve months (41.7% versus 21.1% for RadNet).
RadNet keeps more of each dollar of sales as profit, with a net margin of −0.94% compared with −37.9% at Guardant Health.
Guardant Health scores higher on the StockData Score (9 against 7 for RadNet), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GH | RDNT |
|---|---|---|
| Size and price | ||
| Market cap | $20.8B | $6.1B |
| Share price | $154.78 | $78.08 |
| Change, 1 year | 58.1% | −3.4% |
| Change, 5 years | 58.6% | 176% |
| Beta (5Y) | 1.62 | 1.16 |
| Employees | 2,506 | 76 |
| StockData Score | ||
| Total score | 9 (better) | 7 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 2 (better) |
| Health score | 5 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 16.2× | 2.6× (better) |
| P/B | – | 5.5× |
| EV/EBITDA | – | 27.9× |
| FCF yield | −1.1% | – |
| Fair value | – | $55.32 |
| Margin of safety | – | −41.1% |
| Growth | ||
| Revenue growth (TTM) | 41.7% (better) | 21.1% |
| Revenue growth, 5Y average | 27.9% (better) | 13.7% |
| Profitability | ||
| Gross margin | 65.2% | – |
| Operating margin | −39.4% | 3.1% (better) |
| Net margin | −37.9% | −0.94% (better) |
| FCF margin | −18.2% | – |
| Return on equity | – | −2.1% |
| Return on invested capital | – | 2.8% |
| Financial health | ||
| Debt / equity | – | 1.18 |
| Net debt / EBITDA | – | 2.28 |
| Interest coverage | −96.6× | 1.0× (better) |
| Current ratio | 3.60 (better) | 1.49 |
| Altman Z-score | 3.69 (better) | 1.97 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 99.8% | 104% |
| Held by insiders | 1.8% | 4.6% |
| Insider net buying, 12 months | −$173M | −$8.4M (better) |
| Short interest, % of float | 7.2% | 11.8% |
Go deeper
- GH stock overview
- GH income statement
- GH valuation and score
- RDNT stock overview
- RDNT income statement
- RDNT valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.